Inizio
Generated by Meeveem AI
"Global clinical development and commercialisation partner for health and life sciences companies"
About Inizio
Inizio is a global group supporting pharmaceutical, biotechnology and other health and life sciences organisations through clinical development and commercialisation. Formed in 2022 when Ashfield and Huntsworth combined, it works with more than 700 pharma and biotech companies, from early drug development through medicine launches and beyond.
Its five businesses are Inizio Ignite, Medical, Evoke, Engage and Biotech. Their work spans strategy and insights, medical affairs and scientific communications, marketing, patient support and commercial engagement. Inizio Medical brings together specialist communications agencies producing content for medical communities. The group reports more than 10,900 specialists across 50 countries, combining scientific, clinical, creative and commercial expertise.
Learning across the group
Inizio’s learning approach combines experience, learning from others and formal education through a 70-20-10 model. Employees and managers develop plans together, with common standards for setting goals and reviewing performance. Business-specific programmes address the capabilities needed by different teams.
Support and progression
HR teams across Inizio manage talent development and succession planning, with business leaders accountable for the results. Group-wide wellbeing initiatives sit alongside resources offered by individual businesses, so the support and working arrangements available depend on the employing team.
10900
Team Members
2022
Founded
Consulting
Sector
Hybrid
Work Environment